Mirjana Ziemer

4.1k total citations
138 papers, 1.7k citations indexed

About

Mirjana Ziemer is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, Mirjana Ziemer has authored 138 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Dermatology, 41 papers in Oncology and 33 papers in Epidemiology. Recurrent topics in Mirjana Ziemer's work include Cancer and Skin Lesions (19 papers), Cutaneous Melanoma Detection and Management (16 papers) and Autoimmune Bullous Skin Diseases (15 papers). Mirjana Ziemer is often cited by papers focused on Cancer and Skin Lesions (19 papers), Cutaneous Melanoma Detection and Management (16 papers) and Autoimmune Bullous Skin Diseases (15 papers). Mirjana Ziemer collaborates with scholars based in Germany, United States and Austria. Mirjana Ziemer's co-authors include Peter Elsner, Johannes Norgauer, Martin Kaatz, Martin Johannes Koehler, Karsten König, Robin Reschke, Klaus Eisendle, Enrico Dimitrow, Bernhard Zelger and Jan‐Christoph Simon and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Mirjana Ziemer

121 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirjana Ziemer Germany 23 547 476 355 288 260 138 1.7k
Carlo Cota Italy 26 623 1.1× 1.1k 2.3× 537 1.5× 351 1.2× 322 1.2× 115 2.1k
Marco Manfredini Italy 23 473 0.9× 588 1.2× 316 0.9× 229 0.8× 82 0.3× 90 1.4k
Marco Ardigò Italy 29 667 1.2× 1.4k 3.0× 788 2.2× 135 0.5× 439 1.7× 137 2.4k
Maria Angelica Selim United States 21 401 0.7× 204 0.4× 265 0.7× 380 1.3× 232 0.9× 53 1.3k
Pedro Redondo Spain 25 603 1.1× 523 1.1× 411 1.2× 277 1.0× 178 0.7× 146 1.9k
Elena Sotiriou Greece 25 594 1.1× 1.2k 2.4× 1.1k 3.2× 185 0.6× 248 1.0× 96 2.2k
Caterina Catricalà Italy 29 1.6k 2.9× 1.0k 2.2× 932 2.6× 639 2.2× 272 1.0× 74 2.7k
Sander R. Dubovy United States 37 582 1.1× 168 0.4× 596 1.7× 603 2.1× 179 0.7× 232 5.9k
Anjela Galan United States 17 307 0.6× 240 0.5× 286 0.8× 185 0.6× 228 0.9× 57 1.1k
Dario Didona Italy 20 328 0.6× 528 1.1× 483 1.4× 232 0.8× 235 0.9× 90 1.8k

Countries citing papers authored by Mirjana Ziemer

Since Specialization
Citations

This map shows the geographic impact of Mirjana Ziemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjana Ziemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjana Ziemer more than expected).

Fields of papers citing papers by Mirjana Ziemer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjana Ziemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjana Ziemer. The network helps show where Mirjana Ziemer may publish in the future.

Co-authorship network of co-authors of Mirjana Ziemer

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjana Ziemer. A scholar is included among the top collaborators of Mirjana Ziemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjana Ziemer. Mirjana Ziemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kluger, Harriet M., Götz Ulrich Grigoleit, Sajeve Thomas, et al.. (2025). Lifileucel tumor‐infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhibitors. Cancer Communications. 45(10). 1229–1234. 3 indexed citations
3.
Schmidt, Maria, Carolyn J. Schultz, Henry Loeffler‐Wirth, et al.. (2025). Single‐cell transcriptomics and epigenomics point to CD58‐CD2 interaction in controlling primary melanoma growth and immunity. Cancer Communications. 45(4). 465–470.
4.
Ziemer, Mirjana & Elisabeth Livingstone. (2025). Exanthematische Arzneimittelreaktionen. PubMed. 46(2). 90–100.
5.
Meier, Friedegund, Jörg Otte, Patrick Petzsch, et al.. (2024). Gene expression profiling in porocarcinoma indicates heterogeneous tumor development and substantiates poromas as precursor lesions. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(8). 1115–1124.
6.
Sekulović, Lidija Kandolf, Friedegund Meier, Thomas Eigentler, et al.. (2024). LBA45 Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial. Annals of Oncology. 35. S1235–S1236. 1 indexed citations
7.
Grunwald, Martin, Jens Stieler, Max Holzer, et al.. (2024). Number of Facial Hair Corresponds to Frequency of Spontaneous Face‐Touch in Humans. Advanced Biology. 9(2). e2400243–e2400243. 1 indexed citations
8.
Horn, Susanne, et al.. (2024). Clinical and histopathological features of advanced cutaneous squamous cell carcinoma with varying responses to cemiplimab. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 23(1). 30–37.
9.
Utikal, Jochen, Verena Müller, Jürgen C. Becker, et al.. (2024). S1‐Guideline Sebaceous Carcinoma. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(5). 730–747. 3 indexed citations
10.
11.
Löffler, Dennis, Conny Blumert, Kristin Reiche, et al.. (2023). Atypisches Fibroxanthom und pleomorphes dermales Sarkom – Genexpressionsanalyse im Vergleich zum entdifferenzierten Plattenepithelkarzinom der Haut. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 21(5). 482–492.
12.
Schneider, M., et al.. (2021). Generation of Pigmented Skin Grafts from Human Hair Follicles and Dermal Fibroblasts. Tissue Engineering Part A. 27(19-20). 1333–1342.
13.
Westphal, Dana, Harald Surowy, Friedegund Meier, et al.. (2021). Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies. Cancer Gene Therapy. 29(6). 697–708. 16 indexed citations
14.
Ziemer, Mirjana, et al.. (2021). Complete Remission of Basal Cell Carcinoma Following Treatment With Cemiplimab After 2 Years. JAMA Dermatology. 157(8). 1004–1004. 9 indexed citations
15.
Kendler, Michael, et al.. (2019). Maligner Kollisionstumor der Haut. Der Pathologe. 40(5). 534–538. 3 indexed citations
16.
Magerl, Markus, Jochen Brasch, Ulrike Förster, et al.. (2012). Diagnostik und Ausschluss des hereditären Angioödems: Ein standardisierter Ansatz für die Praxis. Der Hautarzt. 63(7). 567–572. 1 indexed citations
17.
Seyfarth, Florian, Mirjana Ziemer, Herbert G. Sayer, et al.. (2008). The use of ITS DNA sequence analysis and MALDI‐TOF mass spectrometry in diagnosing an infection with Fusarium proliferatum. Experimental Dermatology. 17(11). 965–971. 45 indexed citations
18.
Ziemer, Mirjana, Florian Seyfarth, Peter Elsner, & Uta‐Christina Hipler. (2007). Atypical manifestations of tinea corporis. Mycoses. 50(s2). 31–35. 14 indexed citations
19.
Hoek, Keith S., et al.. (2006). Potassium channel expression profiles in human melanoma cells.. Cancer Research. 66. 1179–1180. 1 indexed citations
20.
Ziemer, Mirjana, et al.. (2006). Treatment of Superficial Surgical Wounds after Removal of Seborrheic Keratoses: A Single-Blinded Randomized-Controlled Clinical Study. Dermatologic Surgery. 32(5). 661–668. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlo Cota Breakdown of academic impact, for papers by Marco Manfredini Breakdown of academic impact, for papers by Marco Ardigò Breakdown of academic impact, for papers by Maria Angelica Selim Breakdown of academic impact, for papers by Pedro Redondo Breakdown of academic impact, for papers by Elena Sotiriou Breakdown of academic impact, for papers by Caterina Catricalà Breakdown of academic impact, for papers by Sander R. Dubovy Breakdown of academic impact, for papers by Anjela Galan Breakdown of academic impact, for papers by Dario Didona
Rankless by CCL
2026